MedPath

An observational study examining bioactive substances and genetic polymorphism for personalized pharmacotherapy in hyperlipidemia

Not Applicable
Recruiting
Conditions
Hyperlipidemia
Registration Number
JPRN-UMIN000006018
Lead Sponsor
Osaka City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) minors 2) Patients with no written informed consent 3) Patients with past history of drug allergy 4) Patients who are inadequate for drug usage 5) Patients with abnormal values of laboratory tests 6) Pregnant women, or nursing women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy and safety of lipid-lowering drugs
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath